Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Orthostatic; Hypotension, Neurogenic”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Large-scale testing (Phase 3)Ended earlyNCT03829657
What this trial is testing

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSAParkinson's Disease (PD)+1 more
Theravance Biopharma 203
Not applicableStudy completedNCT03593512
What this trial is testing

Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System Atrophy

Who this might be right for
Multiple System AtrophyAutonomic FailurePostural Hypotension+2 more
University of Oxford 5
Testing effectiveness (Phase 2)Study completedNCT02784535
What this trial is testing

Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)

Who this might be right for
Neurogenic Orthostatic Hypotension
Vanderbilt University Medical Center 48
Not applicableLooking for participantsNCT05908760
What this trial is testing

CO2 Rebreathing in nOH: A Proof-of-Concept Pilot Study

Who this might be right for
Neurogenic Orthostatic HypotensionAutonomic Failure
University of Calgary 28
Early research (Phase 1)Study completedNCT01149629
What this trial is testing

Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Chelsea Therapeutics 24
Not applicableNot Yet RecruitingNCT07706829
What this trial is testing

Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study

Who this might be right for
Parkinson Disease (PD)REM Sleep Behavior Disorder (iRBD)Neurogenic Orthostatic Hypotension+1 more
Queen Mary University of London 60
Not applicableStudy completedNCT01316666
What this trial is testing

Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic Hypotension

Who this might be right for
Orthostatic HypotensionPure Autonomic FailureMultiple System Atrophy+1 more
Vanderbilt University Medical Center 50
Testing effectiveness (Phase 2)Ended earlyNCT00977171
What this trial is testing

Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome

Who this might be right for
Chronic Fatigue SyndromeOrthostatic HypotensionNeurally Mediated Hypotension+1 more
Chelsea Therapeutics 3
Post-approval studies (Phase 4)Study completedNCT00046475
What this trial is testing

Patients With Neurogenic Orthostatic Hypotension

Who this might be right for
Hypotension, Orthostatic
Shire 140
Post-approval studies (Phase 4)Ended earlyNCT00046163
What this trial is testing

A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension

Who this might be right for
Hypotension, Orthostatic
Shire 150
Post-approval studies (Phase 4)Study completedNCT03602014
What this trial is testing

Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury

Who this might be right for
Hypotension, OrthostaticHypotensionSpinal Cord Injuries
James J. Peters Veterans Affairs Medical Center 22
Not applicableLooking for participantsNCT05369520
What this trial is testing

Non-invasive Spinal Cord Stimulation for Recovery of Autonomic Function After Spinal Cord Injury

Who this might be right for
Spinal Cord InjuryAutonomic DysfunctionSexual Dysfunction+4 more
University of British Columbia 30
Post-approval studies (Phase 4)Study completedNCT00555880
What this trial is testing

Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension

Who this might be right for
Hypotension, Orthostatic
Shire 24
Very early researchEnded earlyNCT02963181
What this trial is testing

Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension

Who this might be right for
Hypotension, OrthostaticHypertensionAutonomic Nervous System Diseases
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10
Large-scale testing (Phase 3)Study completedNCT00782340
What this trial is testing

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 263
Testing effectiveness (Phase 2)Study completedNCT01971008
What this trial is testing

Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD)

Who this might be right for
Parkinson's DiseaseNeurogenic Orthostatic Hypotension in Parkinson's Disease
Medical University Innsbruck 15
Post-approval studies (Phase 4)Study completedNCT03229174
What this trial is testing

Brain Perfusion & Oxygenation in Parkinson's Disease With NOH

Who this might be right for
Parkinson DiseaseNeurogenic Orthostatic Hypotension
William Ondo, MD 17
Very early researchStudy completedNCT04620382
What this trial is testing

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

Who this might be right for
Neurogenic Orthostatic HypotensionAutonomic FailurePure Autonomic Failure+2 more
Vanderbilt University Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT02705755
What this trial is testing

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Who this might be right for
Neurogenic Orthostatic HypotensionMultiple System Atrophy (MSA) With Orthostatic HypotensionPure Autonomic Failure+5 more
Theravance Biopharma 34
Post-approval studies (Phase 4)UnknownNCT04128137
What this trial is testing

Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension

Who this might be right for
Neurogenic Orthostatic Hypotension
H.A.C. PHARMA 90
Next Page